⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.

Item

http://www.wikidata.org/entity/Q53515259

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@en

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@nl

type

Item

label

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@en

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@nl

prefLabel

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@en

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@nl

P1476

⁹⁹mTc-3PRGD₂ SPECT to monitor ...... tage II and III breast cancer.

@en

P2093

Bin Chen

http://www.w3.org/2001/XMLSchema#string

Bin Ji

http://www.w3.org/2001/XMLSchema#string

Minglong Chen

http://www.w3.org/2001/XMLSchema#string

Qingjie Ma

http://www.w3.org/2001/XMLSchema#string

Shi Gao

http://www.w3.org/2001/XMLSchema#string

Tiefeng Ji

http://www.w3.org/2001/XMLSchema#string

Ting Wang

http://www.w3.org/2001/XMLSchema#string

Xueju Wang

http://www.w3.org/2001/XMLSchema#string

Yan Song

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in evaluation of response to neoadjuvant breast cancer treatment

Prognostic value of vascular endothelial growth factor in breast cancer.

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.

Why integrin as a primary target for imaging and therapy.

The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study

Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.

Residual cancer burden in locally advanced breast cancer: a superior tool.

Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.

Integrin α(v)β₃-targeted radiotracer (99m)Tc-3P-RGD₂ useful for noninvasive monitoring of breast tumor response to antiangiogenic linifanib therapy but not anti-integrin α(v)β₃ RGD₂ therapy.

P2888

s00259-015-3062-1

P304

1362-1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-015-3062-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276070792

http://www.w3.org/2001/XMLSchema#string

P698

25947573

http://www.w3.org/2001/XMLSchema#string